<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Auguste G</submitter><funding>NHLBI NIH HHS</funding><funding>NIH HHS</funding><pagination>678-692</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5834384</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>122(5)</volume><pubmed_abstract>RATIONALE:Mutations in the LMNA gene, encoding nuclear inner membrane protein lamin A/C, cause distinct phenotypes, collectively referred to as laminopathies. Heart failure, conduction defects, and arrhythmias are the common causes of death in laminopathies. OBJECTIVE:The objective of this study was to identify and therapeutically target the responsible mechanism(s) for cardiac phenotype in laminopathies. METHODS AND RESULTS:Whole-heart RNA sequencing was performed before the onset of cardiac dysfunction in the Lmna-/- and matched control mice. Differentially expressed transcripts and their upstream regulators were identified, validated, and targeted by adeno-associated virus serotype 9-short hairpin RNA constructs. A total of 576 transcripts were upregulated and 233 were downregulated in </pubmed_abstract><journal>Circulation research</journal><pubmed_title>Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies.</pubmed_title><pmcid>PMC5834384</pmcid><funding_grant_id>R01 HL117641</funding_grant_id><funding_grant_id>R01 HL132401</funding_grant_id><funding_grant_id>R01 HL091947</funding_grant_id><funding_grant_id>S10 OD018135</funding_grant_id><funding_grant_id>R41 HL129570</funding_grant_id><funding_grant_id>R01 HL088498</funding_grant_id><funding_grant_id>R01 HL089598</funding_grant_id><pubmed_authors>Auguste G</pubmed_authors><pubmed_authors>Gurha P</pubmed_authors><pubmed_authors>Coarfa C</pubmed_authors><pubmed_authors>Marian AJ</pubmed_authors><pubmed_authors>Willerson JT</pubmed_authors><pubmed_authors>Lombardi R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Suppression of Activated FOXO Transcription Factors in the Heart Prolongs Survival in a Mouse Model of Laminopathies.</name><description>RATIONALE:Mutations in the LMNA gene, encoding nuclear inner membrane protein lamin A/C, cause distinct phenotypes, collectively referred to as laminopathies. Heart failure, conduction defects, and arrhythmias are the common causes of death in laminopathies. OBJECTIVE:The objective of this study was to identify and therapeutically target the responsible mechanism(s) for cardiac phenotype in laminopathies. METHODS AND RESULTS:Whole-heart RNA sequencing was performed before the onset of cardiac dysfunction in the Lmna-/- and matched control mice. Differentially expressed transcripts and their upstream regulators were identified, validated, and targeted by adeno-associated virus serotype 9-short hairpin RNA constructs. A total of 576 transcripts were upregulated and 233 were downregulated in </description><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Mar</publication><modification>2025-04-19T15:19:45.812Z</modification><creation>2019-08-04T07:29:49Z</creation></dates><accession>S-EPMC5834384</accession><cross_references><pubmed>29317431</pubmed><doi>10.1161/circresaha.117.312052</doi><doi>10.1161/CIRCRESAHA.117.312052</doi></cross_references></HashMap>